AssetMark’s Definium Therapeutics DFTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DFTX
AssetMark's DFTX Position: Q3 2026 in Review
AssetMark increased its Definium Therapeutics (DFTX) stake by 0.86% in Q3 2026, buying an estimated $144K and bringing the position to 399,964 shares worth $15.2M. The position accounts for 0.03% of the portfolio, ranked #461.
AssetMark first reported a position in DFTX in Q2 2023 and has held it in 3 quarters since. The position peaked at $18.7M in Q2 2026. 253 funds tracked by Wall St. Rank hold DFTX as of Q3 2026.
- AssetMark held 399,964 shares of Definium Therapeutics worth $15.2M as of Q3 2026.
- AssetMark bought 3,422 Definium Therapeutics shares in Q3 2026, an estimated $144K.
- Definium Therapeutics made up 0.03% of AssetMark's portfolio in Q3 2026, its #461 holding.
- AssetMark first reported a position in Definium Therapeutics in Q2 2023 and has held it in 3 quarters since.
- AssetMark's Definium Therapeutics position peaked at $18.7M in Q2 2026.
- 253 funds tracked by Wall St. Rank held Definium Therapeutics as of Q3 2026.
Based on AssetMark's 13F filing for Q3 2026, filed 21 Oct 2026.